Literature DB >> 24824077

Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Rie Sato1, Masashi Kishiwada, Naohisa Kuriyama, Yoshinori Azumi, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata, Tomomi Yamada, Shuji Isaji.   

Abstract

BACKGROUND: The aim of the present study was to evaluate perioperative risk factors for development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy (PD), paying special attention to remnant pancreatic volume (RPV) and postoperative infection.
METHODS: We reviewed the charts of 110 patients who had been followed more than 6 months after PD. These patients were classified into the two groups according to RPV measured by CT volumetry at one month: large-volume group (LVG) (10 ml or more, n = 75) and small-volume group (SVG) (less than 10 ml, n = 35).
RESULTS: Nonalcoholic fatty liver disease developed in 44 (40.0%), being significantly higher in SVG than in LVG: 54.2% vs. 33.3% (P = 0.037). SVG was characterized as significantly higher incidence of pancreatic adenocarcinoma, while LVG was characterized as significantly higher incidences of soft pancreas, postoperative infection and pancreatic fistula. In LVG, the incidence of NAFLD was significantly higher in patients with suspicion of infection than in those without it: 45.2% vs. 18.1% (P = 0.014), while not different in SVG. By multivariate analysis, independent risk factor was determined as RPV and suspicion of infection in the whole patients, and in LVG it was suspicion of infection, while in SVG it was not identified.
CONCLUSION: After PD, RPV and status of postoperative infection paradoxically influenced the development of NAFLD.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Gut-derived endotoxin; Multiple parallel hit theory; Nonalcoholic steatohepatitis; Pancreatic exocrine insufficiency; Pancreatic fistula

Mesh:

Year:  2014        PMID: 24824077     DOI: 10.1002/jhbp.115

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  12 in total

1.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

2.  Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer.

Authors:  Keita Kouzu; Hironori Tsujimoto; Makoto Nishikawa; Manabu Harada; Takao Sugihara; Hiromi Nagata; Shuichi Hiraki; Yoshihisa Yaguchi; Risa Takahata; Shinsuke Nomura; Nozomi Ito; Yusuke Ishibashi; Yujiro Itazaki; Satoshi Tsuchiya; Kazuo Hase; Yoji Kishi; Hideki Ueno
Journal:  Gastric Cancer       Date:  2019-09-25       Impact factor: 7.370

Review 3.  Pathophysiology after pancreaticoduodenectomy.

Authors:  Chang Moo Kang; Jin Ho Lee
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Kensuke Yamamura; Yo-Ichi Yamashita; Takanobu Yamao; Yuki Kitano; Kota Arima; Tatsunori Miyata; Takaaki Higashi; Hiromitsu Hayashi; Toru Beppu; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2022-02-12

5.  Functional and morphological evolution of remnant pancreas after resection for pancreatic adenocarcinoma.

Authors:  Shin-Young Park; Keun-Myoung Park; Woo Young Shin; Yun-Mee Choe; Yoon-Seok Hur; Keon-Young Lee; Seung-Ik Ahn
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Authors:  Aoi Hayasaki; Yasuhiro Murata; Masanobu Usui; Taemi Hibi; Takehiro Fujii; Yusuke Iizawa; Hiroyuki Kato; Akihiro Tanemura; Yoshinori Azumi; Naohisa Kuriyama; Masashi Kishiwada; Shugo Mizuno; Hiroyuki Sakurai; Katsunori Uchida; Shuji Isaji
Journal:  Biomed Res Int       Date:  2019-04-04       Impact factor: 3.411

7.  A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.

Authors:  Ryosuke Desaki; Shugo Mizuno; Akihiro Tanemura; Masashi Kishiwada; Yasuhiro Murata; Yoshinori Azumi; Naohisa Kuriyama; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Shuji Isaji
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

8.  Perioperative Computed Tomography Assessments of the Pancreas Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.

Authors:  Katsuhisa Ohgi; Yukiyasu Okamura; Yusuke Yamamoto; Ryo Ashida; Takaaki Ito; Teiichi Sugiura; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

9.  Risk factors for development of nonalcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Yoshiro Fujii; Atsushi Nanashima; Masahide Hiyoshi; Naoya Imamura; Koichi Yano; Takeomi Hamada
Journal:  Ann Gastroenterol Surg       Date:  2017-07-20

10.  Prediction of clinically relevant Pancreatico-enteric Anastomotic Fistulas after Pancreatoduodenectomy using deep learning of Preoperative Computed Tomography.

Authors:  Wei Mu; Chang Liu; Feng Gao; Yafei Qi; Hong Lu; Zaiyi Liu; Xianyi Zhang; Xiaoli Cai; Ruo Yun Ji; Yang Hou; Jie Tian; Yu Shi
Journal:  Theranostics       Date:  2020-08-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.